ArticleJournal of experimental & clinical cancer research : CR2021

LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway.

Ming Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.